Gemini Therapeutics

Gemini Therapeutics is a precision therapy company dedicated to exploring and discovering the genetic nature of "dry" AMD and other related rare hereditary diseases. Based on these genetic findings, the company translates them into corresponding precision-targeted therapies. Its mission is to relentlessly seek precise treatments for AMD and related rare genetic diseases. The company has first-in-class therapy candidates targeting specific genotypes, including monoclonal antibodies, recombinant proteins, and gene therapies, for treating ophthalmic diseases and other rare genetic disorders mediated by complement.